Press release
Agenda announced for FlyPharma Europe
This year, the conference program will offer delegates insight into each supply chain stakeholder's key processes, before discussing the future of the industry. Topics include:
• Inside today's and tomorrow's pharma logistics
• Collaboration: the importance of cross-industry pollination
• Quality control and expectations
• Airline's perspective on pharma import/export
• Data visibility and digitalization
• The role of 'airport cities'
• How pharma can learn from logistics, and vice versa
• Is sustainability the key to better business?
• Logistics academy for shippers
• Market outlook and regulation changes
The conference will cover these areas and more in two days of presentations and panel discussions. There will be plenty of opportunity to put questions to all speakers in live Q&As, or afterwards during extended networking sessions.
Confirmed speakers so far include:
• FLYPHARMA CHAIR: Geert Leroy, Managing Director, Global Pharma Solutions
• Wolfgang Scheibenpflug, Senior Vice President Real Estate and Landside Management, Vienna Airport
• Peter Reulbach, Senior Manager Cargo Business Development, Vienna Airport and Vienna AirportCity
• Christina Norén, Corporate QA GDP Manager, Octapharma
• Isabel Antholz, Managing Director, Mannin GmbH
• Lufthansa Cargo (speaker TBC)
• Yaniv Sorany, Principal IATA Certifications, International Air Transport Association
• Frank Van Gelder, Secretary General, Pharma.Aero
Book your place at www.flypharmaeurope.com/tickets before 24 May and save 10% with discount code EARLY2023.
To propose a speaker, please email angela@samedanltd.com.
Press contact information:
Angela Heath, Conference Director
email: angela@samedanltd.com
Tel: +44 (0)20 7724 3456
Samedan Ltd, 44 Maiden Lane, London WC2E 7LN, UK
About FlyPharma Conferences, Samedan Ltd and PMGroup Worldwide:
FlyPharma Conferences are aimed at forward-thinking individuals and businesses that are ready to uncover the potential in their pharma supply chains. The event offers an interactive platform to discuss current and future challenges within pharma and cargo, with topics including market trends, cold chain innovations, latest regulatory demands, security technology, and how to encourage collaboration between supply chain players. FlyPharma Conferences are run by specialist pharmaceutical publisher Samedan Ltd, which produces a range of market-leading magazines for senior and middle-management professionals across the global pharma and life sciences sectors.
In 2021, Samedan Ltd became part of PMGroup Worldwide Ltd and Datateam Media Group. The acquisition brings together three publishing powerhouses in the pharmaceutical and healthcare sector. As well as joining forces with established titles like PME, PharmaTimes and digital products PMLiVE and pharmatimes.com, PMGroup run a number of awards programmes which recognise best practice in the pharma and healthcare sectors. The union has allowed all brands to expand their readership and their live, virtual and hybrid events and award schemes.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Agenda announced for FlyPharma Europe here
News-ID: 3022673 • Views: …
More Releases from Samedan Ltd
DSV - Global Transport and Logistics will be Gold Sponsors at FlyPharma Copenhag …
When supply chain performance directly impacts patient safety, compliance, and brand reputation, healthcare companies need a logistics partner they can rely on. At DSV, the purpose is to keep customers' supply chains flowing around a world in constant change.
With close to 150,000 employees in over 90 countries, DSV moves millions of shipments for their customers every year by air, sea, road, rail, and contract logistics solutions.
For pharmaceutical and…
Agenda Announced for FlyPharma Copenhagen 2026
FlyPharma, the leading platform for the pharmaceutical logistics and supply chain industry, is excited to announce its agenda for FlyPharma Copenhagen 2026 is now live. Check out the full agenda here: https://flypharmaeurope.com.
Alongside host sponsors Copenhagen Airport, SAS Cargo, and Cencora World Courier, FlyPharma Copenhagen already has the largest number of confirmed exhibitors in FlyPharma history and is set to be the most expansive conference yet.
Taking place on 6-7…
Copenhagen Airports A/S, SAS Cargo and World Courier to Host FlyPharma 2026 in C …
FlyPharma Conferences announce FlyPharma Copenhagen, in partnership with Copenhagen Airport, SAS Cargo, and World Courier, will take place on 6-7 October 2026 at the Clarion Hotel Copenhagen Airport, Copenhagen, Denmark.
FlyPharma is a leading international conference dedicated to the air transport of pharmaceutical products, bringing together airlines, airports, freight forwarders, pharmaceutical manufacturers, regulators, and logistics specialists from across the global supply chain.
Located in the heart of Medicon Valley, Copenhagen has…
FlyPharma 2025 Amsterdam officially announced as contracts are signed with host …
FlyPharma, the leading platform for the pharmaceutical logistics and supply chain industry, is thrilled to announce its ninth European conference, which will take place in Amsterdam from October 8-9, 2025. The FlyPharma Amsterdam 2025 conference will convene industry experts to explore the unique challenges and opportunities facing the region and beyond. In a first for FlyPharma, this year's event is supported by three host sponsors: Amsterdam Airport Schiphol, Air France…
More Releases for Pharma
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed…
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
